The future of osteoarthritis therapeutics: targeted pharmacological therapy
Osteoarthritis (OA) is one of the most common forms of degenerative joint disease and a major cause of pain and disability affecting the aging population. It is estimated that more than 20 million Americans and 35 to 40 million Europeans suffer from OA. Analgesics and non-steroidal anti-inflammatory...
| Main Author: | |
|---|---|
| Format: | Article |
| Published: |
Springer
2013
|
| Subjects: | |
| Online Access: | https://eprints.nottingham.ac.uk/2863/ |